HRS, ACC Lay Out Principles for Same-Day Discharge After Catheter Ablation
With careful consideration of several factors, many patients can avoid an overnight stay, reducing costs without sacrificing safety.
Related Articles
Beyond the Data: The ALIGN-AR Trial
Mamas Mamas sits down with Raj Makkar to discuss new data on the treatment of aortic regurgitation.
Medicaid Patients with Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds
SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.
Funding for Women’s Health Initiative Imperiled, But Appears Secure for Now
Especially given its impact on cardiology, the WHI should be the “pride” of the US, not on the chopping block, says Martha Gulati.
Plant-Derived Compound Shows Early Promise for Small AAAs
In aneurysms normally chosen for surveillance, the endovascular technique slowed growth by 70% in the small phase I trial.
High-Sensitivity Troponin Tests Might Aid in Primary Prevention
Added information from the assays could guide care, especially for intermediate-risk patients on the cusp of initiating statins.
Beyond the Data: The ALIGN-AR Trial
Mamas Mamas sits down with Raj Makkar to discuss new data on the treatment of aortic regurgitation.
Beyond the Data: Ischemia in Women – The WARRIOR Trial
Mamas Mamas, Eileen Handberg, and C. Noel Bairey Merz discuss how the recent WARRIOR trial results can help inform treatment for women with INOCA.
LuX-Valve TTVR Device Provides Favorable 1-Year Results
Where this device will fit in with other emerging options remains to be seen, but it might hold an advantage in large annuli.
Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK
The novel dissolvable therapy had a 93.2% probability of being cost-effective at a modest willingness-to-pay level.
Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE
Ten years after learning their polygenic risk score, patients had fewer events—perhaps due to greater use of statin therapy.
